Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025
Evolent Health (NYSE: EVH) has announced it will release its Q4 2024 financial results on Thursday, February 20, 2025, after market close, followed by a conference call at 5 p.m. ET. Shareholders and analysts can access the live broadcast through Evolent's investor relations website, with analysts able to participate by dialing specific numbers.
The company also announced its executive management team's participation in three upcoming investor conferences in March 2025: the Cowen 45th Annual Health Care Conference in Boston on March 4, the Oppenheimer 35th Annual Health Care MedTech and Services Conference virtually on March 17, and the KeyBanc Annual Health Care Forum virtually on March 19. Audio webcasts will be available on Evolent's investor relations website.
Evolent Health (NYSE: EVH) ha annunciato che rilascerà i risultati finanziari del Q4 2024 giovedì 20 febbraio 2025, dopo la chiusura del mercato, seguiti da una conference call alle 17:00 ET. Gli azionisti e gli analisti possono accedere alla trasmissione in diretta tramite il sito web delle relazioni con gli investitori di Evolent, con gli analisti che possono partecipare componendo numeri specifici.
L'azienda ha inoltre annunciato la partecipazione del suo team di gestione esecutiva a tre conferenze per investitori in programma a marzo 2025: la 45esima Conferenza Annuale sulla Salute di Cowen a Boston il 4 marzo, la 35esima Conferenza Annuale Oppenheimer MedTech e Servizi in modalità virtuale il 17 marzo, e il Forum Annuale sulla Salute di KeyBanc in modalità virtuale il 19 marzo. Le trasmissioni audio saranno disponibili sul sito web delle relazioni con gli investitori di Evolent.
Evolent Health (NYSE: EVH) ha anunciado que publicará sus resultados financieros del Q4 2024 el jueves 20 de febrero de 2025, después del cierre del mercado, seguido de una conferencia telefónica a las 5 p.m. ET. Los accionistas y analistas pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas de Evolent, con los analistas que podrán participar marcando números específicos.
La compañía también anunció la participación de su equipo de gestión ejecutiva en tres conferencias de inversionistas que se llevarán a cabo en marzo de 2025: la 45ª Conferencia Anual de Atención Médica de Cowen en Boston el 4 de marzo, la 35ª Conferencia Anual de MedTech y Servicios de Oppenheimer de forma virtual el 17 de marzo, y el Foro Anual de Atención Médica de KeyBanc de forma virtual el 19 de marzo. Las transmisiones de audio estarán disponibles en el sitio web de relaciones con inversionistas de Evolent.
에볼런트 헬스 (NYSE: EVH)는 2025년 2월 20일 목요일, 시장 폐장 후 2024년 4분기 재무 결과를 발표할 것이라고 발표했습니다. 오후 5시 ET에 이어 회의 전화가 진행됩니다. 주주 및 애널리스트는 에볼런트의 투자자 관계 웹사이트를 통해 실시간 방송에 접근할 수 있으며, 애널리스트는 특정 번호를 호출하여 참여할 수 있습니다.
회사는 또한 2025년 3월에 예정된 세 가지 투자자 컨퍼런스에 경영진이 참여할 것이라고 발표했습니다: 3월 4일 보스턴에서 열리는 코웬 제45회 연례 헬스케어 컨퍼런스, 3월 17일 가상으로 진행되는 오펜하이머 제35회 연례 헬스케어 메드테크 및 서비스 컨퍼런스, 3월 19일 가상으로 열리는 키뱅크 연례 헬스케어 포럼. 오디오 웹캐스트는 에볼런트의 투자자 관계 웹사이트에서 제공될 예정입니다.
Evolent Health (NYSE: EVH) a annoncé qu'il publiera ses résultats financiers du T4 2024 le jeudi 20 février 2025, après la fermeture du marché, suivis d'une conférence téléphonique à 17h00 ET. Les actionnaires et analystes peuvent accéder à la diffusion en direct via le site web des relations avec les investisseurs d'Evolent, avec les analystes pouvant participer en composant des numéros spécifiques.
L'entreprise a également annoncé la participation de son équipe de direction à trois conférences pour investisseurs prévues en mars 2025 : la 45e Conférence Annuelle sur la Santé de Cowen à Boston le 4 mars, la 35e Conférence Annuelle Oppenheimer sur MedTech et les Services virtuellement le 17 mars, et le Forum Annuel sur la Santé de KeyBanc virtuellement le 19 mars. Des rediffusions audio seront disponibles sur le site des relations avec les investisseurs d'Evolent.
Evolent Health (NYSE: EVH) hat angekündigt, dass es seine Finanzergebnisse für das 4. Quartal 2024 am Donnerstag, den 20. Februar 2025, nach Marktschluss veröffentlichen wird, gefolgt von einer Telefonkonferenz um 17:00 Uhr ET. Aktionäre und Analysten können die Live-Übertragung über die Investor-Relations-Website von Evolent abrufen, wobei Analysten durch die Eingabe spezifischer Nummern teilnehmen können.
Das Unternehmen kündigte außerdem die Teilnahme seines Führungsteams an drei bevorstehenden Investorenkonferenzen im März 2025 an: die 45. Jahrestagung zur Gesundheitsversorgung von Cowen in Boston am 4. März, die 35. Jahrestagung für MedTech und Dienstleistungen von Oppenheimer virtuell am 17. März und das Jahresforum zur Gesundheitsversorgung von KeyBanc virtuell am 19. März. Audio-Webcasts sind auf der Investor-Relations-Website von Evolent verfügbar.
- None.
- None.
Company to Participate in Upcoming Conferences
Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.
Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.
An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call.
Upcoming Investor Events
Additionally, Evolent announced that its executive management team will participate in upcoming investor conferences.
A live audio-only webcast and replay for these events will be available on the "Events and Presentations" section of Evolent's investor relations website. Presentation webcast times will be posted on the website as they become available.
- Cowen 45th Annual Health Care Conference at the Boston Marriot Copley Place in
Boston, Massachusetts on March 4, 2025. - Oppenheimer 35th Annual Health Care MedTech and Services Conference to be held virtually on March 17, 2025.
- KeyBanc Annual Health Care Forum to be held virtually on March 19, 2025.
About Evolent
Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting https://ir.evolent.com.
Contacts:
Seth R. Frank
Vice President, Investor Relations
Evolent
sfrank@evolent.com
571-895-3919 (W)
View original content to download multimedia:https://www.prnewswire.com/news-releases/evolent-to-release-fourth-quarter-2024-financial-results-on-thursday-february-20-2025-302361260.html
SOURCE Evolent Health, Inc.
FAQ
When will Evolent Health (EVH) release Q4 2024 earnings?
What time is Evolent Health's (EVH) Q4 2024 earnings call?
Which investor conferences will EVH attend in March 2025?
How can investors access EVH's Q4 2024 earnings call?
